Focused Science
Developing proprietary therapies to address the challenges of antibody-based treatment.
Developing Precision Guided Therapeuticsto Transform Cancer Treatment
Xenagos Bio is a precision oncology company developing novel therapies utilizing our proprietary XenaGuide platform to transform cancer treatment.
Focused oncology development
A clear scientific direction,built for disciplined execution.
Our Approach
Precision guided.Purpose built.
Leveraging cancer's own biology to bring transformative therapies to patients.
Clear Path to Clinical Evidence
Disciplined development to advance IND-enabling studies and clinical proof-of-concept.
Experienced Leadership
The team brings biotechnology, therapeutic development, operations, and corporate growth experience.
Our Focus
Using cancerto fight cancer.
Research Focus
Precision Guided Oncology
The Xenagos platform leverages specific sequences from circulating tumor-derived DNA, called XenaGuides, to target treatment for both hematologic and solid tumors.
Development Focus
Multiple Pathways to Clinical Development
Advancing our platform through disciplined drug development with opportunities to partner.
Leadership
Proven leaders.Deep expertise.
Our team has a track record of advancing innovative therapeutics to meaningful clinical and commercial milestones.
Latest News
Stay informed.
News, press releases, and company updates from Xenagos Bio.